Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Barclays Maintains Overweight on Solid Biosciences, Raises Price Target to $8

Barclays analyst Gena Wang maintains Solid Biosciences (NASDAQ:SLDB) with a Overweight and raises the price target from $2 to $8.
byBenzinga Newsdesk
November 11, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Barclays analyst Gena Wang maintains Solid Biosciences (NASDAQ:SLDB) with a Overweight and raises the price target from $2 to $8.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

What’s Going On With Aterian Shares Today?

By Adam Eckert
Today, 2:45 AM
Aterian Inc (NASDAQ: ATER) is trading higher Monday on abnormally high volume amid increasing retail investor interest.  The total average session volume is about 2 million. The trading volume for Monday's session was about 45 million at publication time.

AMZN